Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine
Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine have?
Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine has 454 citations in the OpenAlex counts ScholarIQ stores.
When was Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine published?
Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine has 2010 year in the ScholarIQ index.
What is the open-access status of Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine?
Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine has green oa status in the ScholarIQ index.
What is the DOI of Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine?
The DOI for Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine is on the source record.
What is the PMID of Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine?
The PMID for Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine is on the source record.
What is the OpenAlex record for Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine?
The OpenAlex for Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine is on the source record.